Advertisement
Advertisement
IRMD
iRadimed Corporation
94.23
USDSponsored
-1.33
-1.39%
Apr 10, 13:04 UTC -4
Open
IRMD Earnings Reports
Positive Surprise Ratio
IRMD beat 35 of 40 last estimates.
88%
Next Report
Date of Next Report
Apr 24, 2026
Estimate for Q1 26 (Revenue/ EPS)
$21.74M
/$0.45
Implied change from Q4 25 (Revenue/ EPS)
-4.19%
/-16.67%
Implied change from Q1 25 (Revenue/ EPS)
+11.43%
/+7.14%
iRadimed Corporation earnings per share and revenue
On Feb 10, 2026, IRMD reported earnings of 0.54 USD per share (EPS) for Q4 25, beating the estimate of 0.48 USD, resulting in a 10.29% surprise. Revenue reached 22.69 million, compared to an expected 22.03 million, with a 3.00% difference. The market reacted with a +1.29% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of 0.45 USD, with revenue projected to reach 21.74 million USD, implying an decrease of -16.67% EPS, and decrease of -4.19% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
Xtant Medical Holdings, Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.00
Actual
$0.00
Surprise
+100.00%
Adagio Medical Holdings, Inc Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$0.31
Actual
-$0.16
Surprise
+49.40%
PAVmed Inc. Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$5.50
Actual
-$5.52
Surprise
-0.22%
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
FAQ
What were iRadimed Corporation's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, iRadimed Corporation reported EPS of $0.54, beating estimates by 10.29%, and revenue of $22.69M, 3% above expectations.
How did the market react to iRadimed Corporation's Q4 2025 earnings?
The stock price moved up 1.29%, changed from $97.92 before the earnings release to $99.18 the day after.
When is iRadimed Corporation expected to report next?
The next earning report is scheduled for Apr 24, 2026.
What are the forecasts for iRadimed Corporation's next earnings report?
Based on 4
analysts, iRadimed Corporation is expected to report EPS of $0.45 and revenue of $21.74M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement